Core Insights - Inspire Medical Systems, Inc. is under investigation by Holzer & Holzer, LLC for potential non-compliance with federal securities laws following the announcement of its second quarter 2025 results [1] - The company reported that the U.S. commercial launch is progressing slower than expected, and the timeline for the full transition to Inspire V has been extended, which will negatively impact financial results for the year [1] - Following this announcement, Inspire Medical's stock price experienced a decline [1] Company Performance - Inspire Medical announced its second quarter 2025 results on August 4, 2025, indicating challenges in its commercial launch and transition timeline [1] - The company has updated its 2025 outlook, suggesting a more cautious financial forecast due to the slower-than-expected progress [1] Legal Context - Holzer & Holzer, LLC is a law firm specializing in securities litigation and is reaching out to investors who may have suffered losses from their investment in Inspire Medical [2] - The firm has a history of representing shareholders and recovering significant amounts for those affected by corporate misconduct [3]
INVESTOR ALERT: Investigation of Inspire Medical Systems, Inc. (INSP) Announced by Holzer & Holzer, LLC